NCT02289001 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Henneman EA, Cunningham H, Roche JP, Curnin ME
Human patient simulation: teaching students to provide safe care. Nurse Educ. 2007 Sep-Oct;32(5):212-7.
Raurell-Torredà M, Olivet-Pujol J, Romero-Collado À, Malagon-Aguilera MC, Patiño-Masó J, Baltasar-Bagué A
Case-based learning and simulation: useful tools to enhance nurses' education? Nonrandomized controlled trial. J Nurs Scholarsh. 2015 Jan;47(1):34-42. doi: 10.1111/jnu.12113. Epub 2014 Oct 25.
Sigalet E, Donnon T, Cheng A, Cooke S, Robinson T, Bissett W, Grant V
Development of a team performance scale to assess undergraduate health professionals. Acad Med. 2013 Jul;88(7):989-96. doi: 10.1097/ACM.0b013e318294fd45.
Wolf L, Dion K, Lamoureaux E, Kenny C, Curnin M, Hogan MA, Roche J, Cunningham H
Using simulated clinical scenarios to evaluate student performance. Nurse Educ. 2011 May-Jun;36(3):128-34. doi: 10.1097/NNE.0b013e318216120b. Review.

Study to Evaluate the Use of the SBAR (Situation-Background-Assessment-Recommendation) Checklist as a Means to Help Undergraduate Nursing Students Understand Team Member Roles and Improve Healthcare Team Communication

Details for clinical trial NCT02289001

Clinical trial NCT02289001 - References